NeuralStem

About:

Neuralstem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.

Website: http://www.neuralstem.com

Twitter/X: Neuralstem_Inc

Top Investors: Hercules Capital, Tianjin Pharmaceutical Group International Holdings

Description:

Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem's research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.

Total Funding Amount:

$39.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

1996-01-01

Founders:

I. Richard Garr

Number of Employees:

1-10

Last Funding Date:

2019-07-31

IPO Status:

Public

Industries:

© 2025 bioDAO.ai